Us Congress House Bill HR239

Us Congress 2025-2026 Regular Session

• Introduced: 3/21/25
• Refer: 3/21/25

Caption

Raising awareness of the racial disparities in the impact of colorectal cancer on the Black community.

Impact

By urging the Centers for Disease Control and Prevention (CDC) and National Institutes of Health (NIH) to conduct further research, HR239 seeks to develop effective strategies to eliminate these disparities in CRC screening. The resolution specifically encourages state health plans to adapt their policies to cover CRC screenings for younger individuals at increased risk, particularly focusing on the Black community. This recommendation aims to address the need for preventative measures to catch CRC earlier, which dramatically increases survival rates. The potential positive impact of adopting new screening guidelines might save lives and help to reduce the racial gap seen in colorectal cancer outcomes.

Summary

House Resolution 239 (HR239) aims to raise awareness of the significant racial disparities in the impact of colorectal cancer (CRC) on the Black community. Colorectal cancer is identified as the third-most common cancer and the second-leading cause of cancer death in the United States. The resolution highlights alarming statistics, including that Black men have a 20% higher rate of CRC compared to non-Hispanic Whites and a 40% higher mortality rate, while Black women face a 14% higher occurrence and a 25% higher death rate. The resolution underscores how low screening rates contribute significantly to these disparities, with lower rates accounting for an estimated 19% of the racial gap in death rates between the groups.

Contention

Although HR239 is a call to action for public health awareness and policy changes, it might encounter contention concerning resource allocation for increased screening and research in the health sector. Some stakeholders may argue about the practicality and funding required to implement extensive changes in state health plans and the healthcare system at large. Other concerns include how effectively governmental and health institutions can act on the recommendations made in the resolution, and whether there is adequate political will to prioritize colorectal cancer screening initiatives, especially for marginalized communities.